Pyrosequencing for MYD88 L265P Mutation Discriminates between Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma

被引：0
|
作者：
Insuasti-Beltran, G.
Wenceslao, S.
Kang, H.
Gale, J. M.
Czuchlewski, D. R.
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] TriCore Reference Labs, Albuquerque, NM USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1401
引用
收藏
页码：334A / 334A
页数：1
相关论文
共 50 条
  • [31] PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation
    Viscovo, Marcello
    Clemmensen, Mia de Laurent
    Fosso, Federica
    Maiolo, Elena
    Autore, Francesco
    Laurenti, Luca
    Hohaus, Stefan
    Chiusolo, Patrizia
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (04) : 665 - 669
  • [32] Mu heavy chain disease with MYD88 L265P mutation: An unusual manifestation of lymphoplasmacytic lymphoma (vol 17, 63, 2022)
    Baloda, Vandana
    Wheeler, Sarah E.
    Murray, David L.
    Kohlhagen, Mindy C.
    Vos, Jeffrey A.
    Yatsenko, Svetlana A.
    Agha, Mounzer E.
    Djokic, Miroslav
    Swerdlow, Steven H.
    Bailey, Nathanael G.
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [33] MYD88 L265P mutation: a tool for differential diagnosis of indolent lymphoma with overlapping clinicopathologic features?
    Lebherz, M.
    Preukschas, M.
    Hallas, C.
    Tiemann, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 260 - 261
  • [34] MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia
    Poulain, Stephanie
    Roumier, Christophe
    Decambron, Audrey
    Renneville, Aline
    Herbaux, Charles
    Bertrand, Elisabeth
    Tricot, Sabine
    Daudignon, Agnes
    Galiegue-Zouitina, Sylvie
    Theisen, Olivier
    Grardel, Nathalie
    Soenen, Valerie
    Nibourel, Olivier
    Roche-Lestienne, Catherine
    Quesnel, Bruno
    Duthilleul, Patrick
    Preudhomme, Claude
    Leleu, Xavier
    BLOOD, 2012, 120 (21)
  • [35] MYD88 L265P Somatic Mutation in IgM MGUS
    Landgren, Ola
    Staudt, Louis
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (23): : 2255 - 2256
  • [36] MYD88 (L265P) MUTATION IS ASSOCIATED WITH AN UNFAVORABLE OUTCOME OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Hattori, K.
    Sakata-Yanagimoto, M.
    Okoshi, Y.
    Goshima, Y.
    Yanagimoto, S.
    Nakamoto-Matsubara, R.
    Sato, T.
    Noguchi, M.
    Takano, S.
    Ishikawa, E.
    Yamamoto, T.
    Matsumura, A.
    Chiba, S.
    HAEMATOLOGICA, 2016, 101 : 392 - 393
  • [37] MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma
    Hattori, Keiichiro
    Sakata-Yanagimoto, Mamiko
    Okoshi, Yasushi
    Goshima, Yuki
    Yanagimoto, Shintaro
    Nakamoto-Matsubara, Rie
    Sato, Taiki
    Noguchi, Masayuki
    Takano, Shingo
    Ishikawa, Eichi
    Yamamoto, Tetsuya
    Matsumura, Akira
    Chiba, Shigeru
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (03) : 492 - 494
  • [38] MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity
    Schmidt, Janine
    Federmann, Birgit
    Schindler, Natalie
    Steinhilber, Julia
    Bonzheim, Irina
    Fend, Falko
    Quintanilla-Martinez, Leticia
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (06) : 795 - 803
  • [39] Clinicopathologic Significance of MYD88 L265P Mutation in Diffuse Large B-Cell Lymphoma (DLBCL)
    Talaat, Ahmed
    El-Ashwah, Shaimaa
    Tharwat, Layla
    Eladl, Ahmed
    Shamaa, Sameh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S430 - S430
  • [40] High Frequency of MYD88 L265P Mutation in Primary Ocular Adnexal Marginal Zone Lymphoma and Its Clinicopathologic Correlation A Study From a Single Institution
    Behdad, Amir
    Zhou, Xiao Yi
    Gao, Juehua
    Raparia, Kirlee
    Dittman, David
    Green, Stefan J.
    Qi, Chao
    Betz, Bryan
    Bryar, Paul
    Chen, Qing
    Chen, Yi-Hua
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (04) : 483 - 493
12345